Published in J Lipid Res on May 22, 2008
Inflammation impairs reverse cholesterol transport in vivo. Circulation (2009) 2.86
ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells. Arterioscler Thromb Vasc Biol (2009) 1.55
Interleukin 6 and apolipoprotein E as predictors of acute brain dysfunction and survival in critical care patients. Am J Crit Care (2014) 1.42
Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest (2010) 1.38
The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Dev Immunol (2010) 1.15
Cross-talk between apolipoprotein E and cytokines. Mediators Inflamm (2011) 1.11
Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport. J Lipid Res (2011) 1.04
Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. PLoS One (2011) 1.04
Inflammation stimulates the expression of PCSK9. Biochem Biophys Res Commun (2008) 1.02
Promotion of atherosclerosis by Helicobacter cinaedi infection that involves macrophage-driven proinflammatory responses. Sci Rep (2014) 1.00
Impact of serum amyloid A on high density lipoprotein composition and levels. J Lipid Res (2010) 0.95
The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis. J Biomed Biotechnol (2010) 0.90
HDL and innate immunity: a tale of two apolipoproteins. J Lipid Res (2008) 0.90
Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels. Neurology (2009) 0.89
Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein. Innate Immun (2008) 0.88
Apolipoprotein CI enhances the biological response to LPS via the CD14/TLR4 pathway by LPS-binding elements in both its N- and C-terminal helix. J Lipid Res (2010) 0.84
ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance. J Lipid Res (2010) 0.82
MicroRNA-146 function in the innate immune transcriptome response of zebrafish embryos to Salmonella typhimurium infection. BMC Genomics (2013) 0.82
Influence of apolipoprotein E plasma levels and tobacco smoking on the induction of neutralising antibodies to interferon-beta. J Neurol (2010) 0.81
A non-invasive, rapid method to genotype late-onset Alzheimer's disease-related apolipoprotein E gene polymorphisms. Neural Regen Res (2014) 0.81
Association between apolipoprotein E genotype, chronic liver disease, and hepatitis B virus. Clin Mol Hepatol (2012) 0.80
Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons. J Cell Mol Med (2016) 0.78
Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease. Am J Respir Cell Mol Biol (2016) 0.77
The Helicobacter cinaedi antigen CAIP participates in atherosclerotic inflammation by promoting the differentiation of macrophages in foam cells. Sci Rep (2017) 0.75
Lipopolysaccharide enters the rat brain by a lipoprotein-mediated transport mechanism in physiological conditions. Sci Rep (2017) 0.75
Acute-phase proteins and other systemic responses to inflammation. N Engl J Med (1999) 18.25
Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet (2000) 6.61
Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 5.00
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res (2004) 4.67
Molecular biology of PCSK9: its role in LDL metabolism. Trends Biochem Sci (2007) 3.59
Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science (1995) 3.10
Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol (1999) 2.75
Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J Clin Invest (2004) 2.66
Apolipoprotein-mediated pathways of lipid antigen presentation. Nature (2005) 2.61
Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest (2007) 2.53
Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci U S A (1997) 2.34
Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse. J Clin Invest (1995) 2.04
Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest (1996) 2.03
Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest (1989) 1.92
Serial analysis of gene expression in human monocytes and macrophages. Blood (1999) 1.75
APOE polymorphism is associated with risk of severe sepsis in surgical patients. Crit Care Med (2005) 1.70
Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J Biol Chem (1984) 1.70
Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res (1992) 1.64
Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J Immunol (2004) 1.63
Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis. J Biol Chem (2001) 1.59
Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res (1999) 1.49
Apolipoprotein E suppresses the type I inflammatory response in vivo. Circ Res (2005) 1.48
Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J Lipid Res (1998) 1.35
Endotoxin suppresses expression of apoprotein E by mouse macrophages in vivo and in culture. A biochemical and genetic study. J Biol Chem (1983) 1.31
Altered immune responses in apolipoprotein E-deficient mice. J Lipid Res (2000) 1.31
Distribution of apolipoprotein A-I, C-II, C-III, and E mRNA in fetal human tissues. Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages. Biochemistry (1985) 1.30
Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia. J Clin Invest (2007) 1.22
Apolipoprotein E and renal disease. Am J Kidney Dis (2004) 1.20
Duplicated downstream enhancers control expression of the human apolipoprotein E gene in macrophages and adipose tissue. J Biol Chem (2000) 1.20
Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo. J Clin Invest (1997) 1.18
Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes. J Exp Med (1996) 1.17
Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice. Proc Natl Acad Sci U S A (1999) 1.13
ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res (2001) 1.11
Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J Lipid Res (2003) 1.05
Two hepatic enhancers, HCR.1 and HCR.2, coordinate the liver expression of the entire human apolipoprotein E/C-I/C-IV/C-II gene cluster. J Biol Chem (1997) 1.05
Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J Biol Chem (1999) 1.04
Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae. Eur J Clin Invest (2000) 1.01
Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo. Evidence for retroendocytosis. J Biol Chem (2000) 0.95
Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor. J Lipid Res (2006) 0.95
Apolipoprotein E and the risk of breast cancer in African-American and non-Hispanic white women. A review. Oncology (2004) 0.94
Effect of endotoxin and cytokines on lipoprotein lipase activity in mice. Arterioscler Thromb (1994) 0.93
Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL. J Lipid Res (2006) 0.92
Ability of the LDL receptor from several animal species to recognize the human apo B binding domain: studies with LDL from familial defective apo B-100. Atherosclerosis (1992) 0.92
Preparative free-solution isotachophoresis for separation of human plasma lipoproteins: apolipoprotein and lipid composition of HDL subfractions. J Lipid Res (2000) 0.90
Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor. Biochim Biophys Acta (2004) 0.90
Altered hepatic production of apolipoproteins B and E in the fasted septic rat: factors in the development of hypertriglyceridemia. J Surg Res (1993) 0.86
LPS and cytokines regulate extra hepatic mRNA levels of apolipoproteins during the acute phase response in Syrian hamsters. Biochim Biophys Acta (1997) 0.83
Endotoxin suppresses mouse hepatic low-density lipoprotein-receptor expression via a pathway independent of the toll-like receptor 4. Hepatology (1999) 0.82
Both the polysaccharide and lipid A parts of endotoxins are needed for the inhibitory effects of endotoxins on cellular LDL uptake. Scand J Clin Lab Invest (1992) 0.80
Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res (2005) 2.16
High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res (2005) 1.77
Components of metabolic syndrome and metachronous colorectal neoplasia. Cancer Epidemiol Biomarkers Prev (2009) 1.52
Race and ethnicity and breast cancer outcomes in an underinsured population. J Natl Cancer Inst (2010) 1.33
High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays. BMC Med Genomics (2009) 1.29
Long-term anti-inflammatory and antihistamine medication use and adult glioma risk. Cancer Epidemiol Biomarkers Prev (2008) 1.28
Association between body size and colorectal adenoma recurrence. Clin Gastroenterol Hepatol (2007) 1.28
Diet and nutrient factors in colorectal cancer risk. Nutr Clin Pract (2012) 1.22
Diet, gender, and colorectal neoplasia. J Clin Gastroenterol (2007) 1.21
Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol (2009) 1.21
Relationship between epidemiologic risk factors and breast cancer recurrence. J Clin Oncol (2007) 1.21
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. Prostate (2012) 1.15
Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy. J Womens Health (Larchmt) (2009) 1.12
Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity. Prostate (2010) 1.06
Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins. J Lipid Res (2003) 1.05
Serum 25(OH)D levels, dietary intake of vitamin D, and colorectal adenoma recurrence. J Steroid Biochem Mol Biol (2007) 1.04
Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. Cancer Res (2010) 1.04
Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis. FASEB J (2006) 1.03
Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells. Mol Carcinog (2010) 1.03
Changes in body weight and metabolic indexes in overweight breast cancer survivors enrolled in a randomized trial of low-fat vs. reduced carbohydrate diets. Nutr Cancer (2010) 1.03
Reproductive factors, heterogeneity, and breast tumor subtypes in women of mexican descent. Cancer Epidemiol Biomarkers Prev (2013) 1.02
What can we learn about disease etiology from case-case analyses? Lessons from breast cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.01
Stimulus-dependent deacylation of bacterial lipopolysaccharide by dendritic cells. J Exp Med (2003) 0.99
Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. J Biol Chem (2003) 0.99
Nipple aspirate fluid cytology in breast carcinoma. Cancer (2003) 0.97
Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients. J Natl Cancer Inst (2010) 0.96
Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis (2010) 0.96
Factors that influence mammography use and breast cancer detection among Mexican-American and African-American women. Cancer Causes Control (2011) 0.95
Fiber, sex, and colorectal adenoma: results of a pooled analysis. Am J Clin Nutr (2006) 0.95
Plasma insulin-like growth factor I is inversely associated with colorectal adenoma recurrence: a novel hypothesis. Cancer Epidemiol Biomarkers Prev (2008) 0.95
High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer. Clin Cancer Res (2003) 0.93
Predictors of recurrence free survival for patients with stage II and III colon cancer. BMC Cancer (2014) 0.92
Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer. Cancer Prev Res (Phila) (2010) 0.92
Meat intake, preparation methods, mutagens and colorectal adenoma recurrence. Carcinogenesis (2007) 0.92
Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women's Healthy Eating and Living Study. Breast Cancer Res Treat (2010) 0.91
Primary care physician compliance with colorectal cancer screening guidelines. Cancer Causes Control (2011) 0.90
Expression of gastric pyloric mucin, MUC6, in colorectal serrated polyps. Mod Pathol (2009) 0.89
The CD14 receptor does not mediate entry of Mycobacterium tuberculosis into human mononuclear phagocytes. FEMS Immunol Med Microbiol (2003) 0.89
Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein. Innate Immun (2008) 0.88
The relationship between eight GWAS-identified single-nucleotide polymorphisms and primary breast cancer outcomes. Oncologist (2013) 0.87
MnSOD polymorphism and breast cancer in a population-based case-control study. Cancer Lett (2003) 0.86
Hypothesized role of pregnancy hormones on HER2+ breast tumor development. Breast Cancer Res Treat (2012) 0.86
Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer. Cancer Prev Res (Phila) (2013) 0.86
Dietary patterns, risk and prognosis of breast cancer. Future Oncol (2009) 0.85
Safety and Feasibility of Topical Application of Limonene as a Massage Oil to the Breast. J Cancer Ther (2012) 0.85
Physical activity as a determinant of fecal bile acid levels. Cancer Epidemiol Biomarkers Prev (2009) 0.84
Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival. Breast Cancer Res Treat (2014) 0.84
Variation in cyclooxygenase expression levels within the colorectum. Mol Carcinog (2003) 0.84
Colorectal adenoma stem-like cell populations: associations with adenoma characteristics and metachronous colorectal neoplasia. Cancer Prev Res (Phila) (2013) 0.84
Reproductive and hormonal risk profile according to language acculturation and country of residence in the Ella Binational Breast Cancer Study. J Womens Health (Larchmt) (2014) 0.83
Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins. J Endotoxin Res (2003) 0.83
Native high-density lipoprotein augments monocyte responses to lipopolysaccharide (LPS) by suppressing the inhibitory activity of LPS-binding protein. J Immunol (2006) 0.82
Pilot study on the effects of dietary conjugated linoleic acid on tumorigenesis and gene expression in PyMT transgenic mice. Carcinogenesis (2010) 0.82
Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis. Cancer Prev Res (Phila) (2011) 0.82
Recruitment of lactating women into a randomized dietary intervention: successful strategies and factors promoting enrollment and retention. Contemp Clin Trials (2011) 0.82
ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance. J Lipid Res (2010) 0.82
Genetic variants in the vitamin D pathway and breast cancer disease-free survival. Carcinogenesis (2012) 0.82
Prolonged hepatomegaly in mice that cannot inactivate bacterial endotoxin. Hepatology (2011) 0.81
A comparison of Mediterranean-style and MyPyramid diets on weight loss and inflammatory biomarkers in postpartum breastfeeding women. J Womens Health (Larchmt) (2012) 0.81
t10c12 conjugated linoleic acid suppresses HER2 protein and enhances apoptosis in SKBr3 breast cancer cells: possible role of COX2. PLoS One (2009) 0.81
Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma. Hum Genet (2012) 0.81
Dietary polyamine intake and risk of colorectal adenomatous polyps. Am J Clin Nutr (2012) 0.81
Human papillomavirus type distribution among heterosexual couples. J Low Genit Tract Dis (2012) 0.80
Metabolomic characterization of nipple aspirate fluid by (1)H NMR spectroscopy and GC-MS. J Proteome Res (2014) 0.80
Fruit and vegetable intake and breast cancer risk: a case for subtype-specific risk? J Natl Cancer Inst (2013) 0.79
Dietary polyamine intake and polyamines measured in urine. Nutr Cancer (2014) 0.78
Expression of epidermal growth factor, transforming growth factor-β1 and adiponectin in nipple aspirate fluid and plasma of pre and post-menopausal women. Biomark Res (2013) 0.78
Presence of a TA haplotype in the APC gene containing the common 1822 polymorphism and colorectal adenoma. Cancer Res (2008) 0.78
Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer. Breast Cancer Res Treat (2013) 0.77
Genes in the insulin and insulin-like growth factor pathway and odds of metachronous colorectal neoplasia. Hum Genet (2011) 0.77
Sedentary behavior is associated with colorectal adenoma recurrence in men. Cancer Causes Control (2014) 0.77
Association of obesity and smoking with PSA and PSA velocity in men with prostate cancer. Am J Mens Health (2011) 0.77
Investigating the association of lactation history and postmenopausal breast cancer risk in the Women's Health Initiative. Nutr Cancer (2013) 0.76
Direct reduction of N-acetoxy-PhIP by tea polyphenols: a possible mechanism for chemoprevention against PhIP-DNA adduct formation. Mutat Res (2003) 0.76
Rising Incidence of Colorectal Cancer Among Young Hispanics in Texas. J Clin Gastroenterol (2017) 0.75
Physical Activity Modifies the Association between Dietary Protein and Lean Mass of Postmenopausal Women. J Acad Nutr Diet (2016) 0.75
Perspective: Chemoprevention of colorectal neoplasia: Translating scientific promise into clinical practice. J Carcinog (2011) 0.75
What you should know about psoriasis. Nursing (2008) 0.75
Anal fissure: how to support spontaneous healing. Nursing (2008) 0.75
Planning, conducting, and interpreting prevalence and incidence for the wound practitioner. Adv Skin Wound Care (2013) 0.75
Managing cellulitis and impetigo. Nursing (2008) 0.75
When your patient has atopic dermatitis. Nursing (2008) 0.75